{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:46:02Z","timestamp":1793807162621,"version":"4.6.1"},"reference-count":50,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4,10]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Allo-HSCT using reduced intensity conditioning with alemtuzumab appears to be effective and safe for patients with refractory JIA. Early allo-HSCT may prevent joint damage, reduce toxicity associated with immunosuppression, and reduce transplant-related mortality.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017014449","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T16:00:41Z","timestamp":1522857641000},"page":"777-786","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":60,"title":["Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis"],"prefix":"10.1182","volume":"2","author":[{"given":"Juliana","family":"M. F. Silva","sequence":"first","affiliation":[{"name":"Department of BMT, Great Ormond Street Hospital for Children, National Health Service (NHS) Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fani","family":"Ladomenou","sequence":"additional","affiliation":[{"name":"Department of BMT, Great Ormond Street Hospital for Children, National Health Service (NHS) Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Department of Adolescent BMT, University College Hospital, NHS Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharat","family":"Chandra","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Sedlacek","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Teaching Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Formankova","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Teaching Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Grandage","sequence":"additional","affiliation":[{"name":"Department of Adolescent BMT, University College Hospital, NHS Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Friswell","sequence":"additional","affiliation":[{"name":"Great North Children\u2019s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom;"},{"name":"Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Cant","sequence":"additional","affiliation":[{"name":"Great North Children\u2019s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom;"},{"name":"Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Nademi","sequence":"additional","affiliation":[{"name":"Great North Children\u2019s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom;"},{"name":"Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Slatter","sequence":"additional","affiliation":[{"name":"Great North Children\u2019s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom;"},{"name":"Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[{"name":"Great North Children\u2019s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom;"},{"name":"Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Hambleton","sequence":"additional","affiliation":[{"name":"Great North Children\u2019s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom;"},{"name":"Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"Flood","sequence":"additional","affiliation":[{"name":"Great North Children\u2019s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom;"},{"name":"Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Lucchini","sequence":"additional","affiliation":[{"name":"Department of BMT, Great Ormond Street Hospital for Children, National Health Service (NHS) Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Chiesa","sequence":"additional","affiliation":[{"name":"Department of BMT, Great Ormond Street Hospital for Children, National Health Service (NHS) Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of BMT, Great Ormond Street Hospital for Children, National Health Service (NHS) Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persis J.","family":"Amrolia","sequence":"additional","affiliation":[{"name":"Department of BMT, Great Ormond Street Hospital for Children, National Health Service (NHS) Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brogan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy R.","family":"Wedderburn","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom; and"},{"name":"University College London Great Ormond Street Institute of Child Health and NIHR GOSH Biomedical Research Centre, NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Glanville","sequence":"additional","affiliation":[{"name":"Department of BMT, Great Ormond Street Hospital for Children, National Health Service (NHS) Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Hough","sequence":"additional","affiliation":[{"name":"Department of Adolescent BMT, University College Hospital, NHS Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Marsh","sequence":"additional","affiliation":[{"name":"Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH;"},{"name":"Department of Pediatrics, University of Cincinnati, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Abinun","sequence":"additional","affiliation":[{"name":"Great North Children\u2019s Hospital, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom;"},{"name":"Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Veys","sequence":"additional","affiliation":[{"name":"Department of BMT, Great Ormond Street Hospital for Children, National Health Service (NHS) Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"issue":"1","key":"2019111616204163900_B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14397595.2014.902747","article-title":"Pathogenesis of systemic inflammatory diseases in childhood: \u201cLessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome\u201d","volume":"25","author":"Yokota","year":"2015","journal-title":"Mod Rheumatol"},{"key":"2019111616204163900_B2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2014.01.009","article-title":"Diagnosis and classification of juvenile idiopathic arthritis","volume":"48-49","author":"Eisenstein","year":"2014","journal-title":"J Autoimmun"},{"issue":"10","key":"2019111616204163900_B3","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3201\/eid2210.151245","article-title":"Infection-related death among persons with refractory juvenile idiopathic arthritis","volume":"22","author":"Abinun","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"2019111616204163900_B4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3899\/jrheum.141261","article-title":"Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"42","author":"Minoia","year":"2015","journal-title":"J Rheumatol"},{"issue":"3","key":"2019111616204163900_B5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/INF.0b013e3182833cbb","article-title":"Infections in children treated with biological agents","volume":"32","author":"Woerner","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"2019111616204163900_B6","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"9563","key":"2019111616204163900_B7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"2019111616204163900_B8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2014.212","article-title":"Management of juvenile idiopathic arthritis: hitting the target","volume":"11","author":"Hinze","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"2019111616204163900_B9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00062752-199704060-00005","article-title":"Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease","volume":"4","author":"Tyndall","year":"1997","journal-title":"Curr Opin Hematol"},{"issue":"8","key":"2019111616204163900_B10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/rheumatology\/38.8.764","article-title":"Autologous stem cell transplantation: a possible treatment for refractory juvenile chronic arthritis?","volume":"38","author":"Wulffraat","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"2019111616204163900_B11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.2003.017798","article-title":"Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity","volume":"63","author":"De Kleer","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2019111616204163900_B12","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2019111616204163900_B13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.molimm.2008.12.029","article-title":"Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007)","volume":"47","author":"Abinun","year":"2009","journal-title":"Mol Immunol"},{"issue":"4 Pt 2","key":"2019111616204163900_B14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/pr.2011.66","article-title":"Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases","volume":"71","author":"Tyndall","year":"2012","journal-title":"Pediatr Res"},{"issue":"8","key":"2019111616204163900_B15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/08916930802200224","article-title":"Current perspectives of autologous stem cell transplantation for severe Juvenile Idiopathic Arthritis","volume":"41","author":"Wulffraat","year":"2008","journal-title":"Autoimmunity"},{"issue":"11","key":"2019111616204163900_B16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/sj.bmt.1703686","article-title":"Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases","volume":"30","author":"Hinterberger","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111616204163900_B17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.beha.2004.04.004","article-title":"Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications","volume":"17","author":"Marmont","year":"2004","journal-title":"Best Pract Res Clin Haematol"},{"issue":"6","key":"2019111616204163900_B18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2141.2012.09122.x","article-title":"Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009","volume":"157","author":"Snowden","year":"2012","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111616204163900_B19","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.bbmt.2014.11.039","article-title":"Allogeneic haematopoietic stem cell transplantation for systemic onset juvenile idiopathic arthritis","volume":"21","author":"Silva","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111616204163900_B20","first-page":"26","author":"Greco","year":"2017"},{"key":"2019111616204163900_B21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.trim.2017.02.002","article-title":"Late onset cytopenias following haematopoietic stem cell transplant associated with viral infection and cell specific antibodies","volume":"41","author":"Lucas","year":"2017","journal-title":"Transpl Immunol"},{"issue":"10","key":"2019111616204163900_B22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrrheum.2010.142","article-title":"The safety profile of biologic therapies for juvenile idiopathic arthritis","volume":"6","author":"Hashkes","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"2019111616204163900_B23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2007.087593","article-title":"Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry","volume":"68","author":"Horneff","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"2019111616204163900_B24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2007.069484","article-title":"Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients","volume":"67","author":"Gerloni","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2019111616204163900_B25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/archdischild-2016-311571","article-title":"Mortality rates are increased in patients with systemic juvenile idiopathic arthritis","volume":"102","author":"Davies","year":"2017","journal-title":"Arch Dis Child"},{"issue":"2","key":"2019111616204163900_B26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/imm.12245","article-title":"Immunological characteristics and T-cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T-cell-depleted autologous stem cell transplantation","volume":"142","author":"Wu","year":"2014","journal-title":"Immunology"},{"issue":"4","key":"2019111616204163900_B27","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2005-07-2800","article-title":"Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network","volume":"107","author":"de Kleer","year":"2006","journal-title":"Blood"},{"key":"2019111616204163900_B28","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1017\/erm.2013.14","article-title":"T regulatory cells in childhood arthritis--novel insights","volume":"15","author":"Pesenacker","year":"2013","journal-title":"Expert Rev Mol Med"},{"issue":"1","key":"2019111616204163900_B29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/blood-2015-06-649145","article-title":"Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells","volume":"127","author":"Delemarre","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2019111616204163900_B30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2141.2004.05298.x","article-title":"Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective","volume":"128","author":"Hough","year":"2005","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111616204163900_B31","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"issue":"9","key":"2019111616204163900_B32","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/eji.201546092","article-title":"Understanding inflammation in juvenile idiopathic arthritis: How immune biomarkers guide clinical strategies in the systemic onset subtype","volume":"46","author":"Swart","year":"2016","journal-title":"Eur J Immunol"},{"issue":"7042","key":"2019111616204163900_B33","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nature03728","article-title":"Treatment of severe autoimmune disease by stem-cell transplantation","volume":"435","author":"Sykes","year":"2005","journal-title":"Nature"},{"issue":"2","key":"2019111616204163900_B34","first-page":"237","article-title":"Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia","volume":"1","author":"Jacobs","year":"1986","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2019111616204163900_B35","first-page":"137","article-title":"Apparent cure of rheumatoid arthritis by bone marrow transplantation","volume":"20","author":"Lowenthal","year":"1993","journal-title":"J Rheumatol"},{"key":"2019111616204163900_B36","first-page":"23","article-title":"Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation","volume":"48","author":"Nelson","year":"1997","journal-title":"J Rheumatol Suppl"},{"issue":"7","key":"2019111616204163900_B37","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/art.1780390727","article-title":"Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year followup","volume":"39","author":"McKendry","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2019111616204163900_B38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1704183","article-title":"Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma","volume":"32","author":"Tapprich","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111616204163900_B39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/art.1780200502","article-title":"Bone marrow transplantation in patients with gold-induced marrow aplasia","volume":"20","author":"Baldwin","year":"1977","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2019111616204163900_B40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bmt.2008.424","article-title":"Allogeneic hematopoietic SCT for patients with autoimmune diseases","volume":"44","author":"Daikeler","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111616204163900_B41","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2011-02-336156","article-title":"Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party","volume":"118","author":"Daikeler","year":"2011","journal-title":"Blood"},{"issue":"5980","key":"2019111616204163900_B42","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.328.5980.825-e","article-title":"Risks of immune system treatments","volume":"328","author":"Burt","year":"2010","journal-title":"Science"},{"issue":"5967","key":"2019111616204163900_B43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1126\/science.327.5967.772","article-title":"Immunology. Replacing an immune system gone haywire","volume":"327","author":"Couzin-Frankel","year":"2010","journal-title":"Science"},{"issue":"5","key":"2019111616204163900_B44","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/acr.21889","article-title":"Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis","volume":"65","author":"Kimura","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"2019111616204163900_B45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/rheumatology\/ket314","article-title":"The genetics of juvenile idiopathic arthritis: current understanding and future prospects","volume":"53","author":"Cobb","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"2019111616204163900_B46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11926-013-0406-3","article-title":"Current developments in the use of biomarkers for juvenile idiopathic arthritis","volume":"16","author":"Duurland","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"2019111616204163900_B47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrrheum.2017.7","article-title":"Haematopoietic stem cell transplantation for autoimmune diseases","volume":"13","author":"Swart","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2019111616204163900_B48","first-page":"14","author":"Chandra","year":"2016"},{"issue":"5","key":"2019111616204163900_B49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2019111616204163900_B50","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/7\/777\/880647\/advances014449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/7\/777\/880647\/advances014449.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T21:21:14Z","timestamp":1573939274000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/7\/777\/15813\/Allogeneic-hematopoietic-stem-cell-transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,4,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017014449","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]}}}